By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fujisawa Pharmaceutical Co., Ltd. 

4-7, Doshomachi 3-chome

Chuo-ku  Osaka  541-8514  Japan
Phone: 81-06-6202-1141 Fax: 81-06-6206-7926



Company News
Yamanouchi Pharmaceutical Co., Ltd. And Fujisawa Pharmaceutical Co., Ltd. Unite To Form Astellas Pharma Inc., North American Headquarters To Be In Chicago10/19/2005 5:13:11 PM
Fujisawa Pharmaceutical Co., Ltd. To Outsource Cefzon Bulk Production To API Corporation10/19/2005 5:13:07 PM
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval10/19/2005 5:13:03 PM
Gloucester Pharmaceuticals, Inc. Initiates Pivotal Trial With FK228 In Cutaneous T-Cell Lymphoma; FDA Approves Trial Protocol Under Special Protocol Assessment10/19/2005 5:12:52 PM
Merger Mania Besets Japanese Pharmaceuticals10/19/2005 5:12:49 PM
Fujisawa Pharmaceutical Co., Ltd. And Carlsson Research AB Conclude Licensing Agreement For Antipsychotic Agent ACR-1610/19/2005 5:12:39 PM
Cardiome Pharma Corp. (COM.TO) Completes ACT 3 Enrollment10/19/2005 5:12:08 PM
Yamanouchi Pharmaceutical Co., Ltd., Fujisawa Pharmaceutical Co., Ltd. To Become Astellas Post-Merger; $7.12 Billion10/19/2005 5:11:29 PM
Fujisawa Pharmaceutical Co., Ltd. And Yamanouchi Pharmaceutical Co., Ltd. Will Establish Zepharma Inc., An OTC Pharmaceutical Company10/19/2005 5:11:27 PM
Tercica, Inc. Licenses Patent Rights To rhIGF-1 From Fujisawa Pharmaceutical Co., Ltd. In Extreme Insulin Resistance10/19/2005 5:11:05 PM